EVALUATION OF THE SYNERGISTIC EFFECT OF A NOVEL LENTUSCIN-VANCOMYCIN ANTICANCER AGENT
Authors:
- Mais Emad AhmedMAMais Emad Ahmed
- Lina Abdulameer S. AlsaadiLALina Abdulameer S. Alsaadi
- Rana S. AboudRARana S. Aboud
Open Access
- 15 August 2025
- journal article
- Published by Slovak University of Agriculture in Nitra in Journal of microbiology, biotechnology and food sciences
- p. e12519
Abstract
Vancomycin's declining efficacy against clinical Staphylococcus isolates has sparked worries about the limited availability of antibiotic therapy alternatives. Novel treatments, such as several promising antimicrobial peptides, have come into focus in response. Notably, several experimental investigations have demonstrated the strong biological activity of specific bacteriocins, indicating selective cytotoxicity by specifically targeting distinct cancer cell types in addition to their ability to combat bacterial pathogens. This study succinctly summarizes its objectives, methods, results, and conclusions. The alternative synergistic combination of vancomycin and lentuscin for treating the cancer cell line WRL68 decreased both the cell viability and the IC50 values of A375. The goal of this study was to compare the antimicrobial activity of bacteriocin from Staphylococcus lentus with that of a combination of vancomycin and lentuscin (bacteriocin produced from Staphylococcus lentus). Pathogens like S. lentus were isolated from clinical samples (e.g., mid-stream urine). It is essential to create a novel antimicrobial agent that is synergistic with the antibiotic vancomycin and that has been evaluated for mammalian cell cytotoxicity. The bacteriocin was produced in modified media supplemented with 1% glucose at 37°C for 72 hr with an inoculum size of 1.2 ˟ 109 CFU/ml and a pH of 7. The important steps for the extraction of the bacteriocin were purification with 70% ammonium sulfate salt and purification by DEAE-cellulose chromatography. The alternative synergistic drug vancomycin, combined with lentuscin for treating the cancer cell line, Cell line derived from embryonic liver (WRL68 ), decreased the cell viability and IC50 values of A375. Conclusion This is the first report demonstrating the anticancer properties of lentuscin and vancomycin. Using these bacteriocins as single agents or in combination would be effective against drug-resistant cancer cells with specific cytotoxicity. This is the first report on the synergistic anticancer effect of lentuscin (a bacteriocin from S. lentus) with vancomycin.Keywords
This publication has 30 references indexed in Scilit:
- Bacteriocin isolated from Ralstonia mannitolilytica and bacteriocin-capped silver nanoparticles: Comparative effects on biofilm formation and LuxS Gene's expressions by Proteus mirabilis as an approach to counter MDR catheter infectionMicrobial Pathogenesis, 2025
- Green Synthesis and Characterization of Selenium Nanoparticles via Staphylococcus warneri Approach: Antimicrobial and on PhzM Pyocyanin Gene Expression in Pseudomonas aeruginosaPlasmonics, 2024
- Promising Antimicrobial Activity and Synergy of Bacteriocins Against Mycobacterium tuberculosisMicrobial Drug Resistance, 2023
- Reactive oxygen species generation and mitochondrial dysfunction for the initiation of apoptotic cell death in human hepatocellular carcinoma HepG2 cells by a cyclic dipeptide Cyclo(-Pro-Tyr)Molecular Biology Reports, 2020
- Actinomyces Produces Defensin-Like Bacteriocins (Actifensins) with a Highly Degenerate Structure and Broad Antimicrobial ActivityJournal of Bacteriology, 2020
- Effects of Enterococcus faecalis UGRA10 and the enterocin AS-48 against the fish pathogen Lactococcus garvieae. Studies in vitro and in vivoFood Microbiology, 2019
- Nisin, a potent bacteriocin and anti-bacterial peptide, attenuates expression of metastatic genes in colorectal cancer cell linesMicrobial Pathogenesis, 2018
- The study of Bacteriocin of Pseudomonas fluorescens and Citrus limon effects against Propionibacterium acnes and Staphylococcus epidermidis in acne patientsJournal of Physics: Conference Series, 2018
- Microcin E492, a channel-forming bacteriocin from Klebsiella pneumoniae , induces apoptosis in some human cell linesProceedings of the National Academy of Sciences, 2002
- Preliminary characterization of bacteriocins produced by Enterococcus faecium and Enterococcus faecalis isolated from pig faecesJournal of Applied Microbiology, 2000